Centrose LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centrose LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10607
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centrose LLC (Centrose) is a precision drug company that develops medicines to target diseased tissues. The company’s product pipeline includes EDC1 (Dysadherin), EDC2 (CD147), EDC3 (CD98), EDC5 (CD44), and EDC8 (CD38). Its product EDC1 combines two proteins found in close proximity to treat cancer cell types. Centrose’s EDC5 targets the cell surface of cancer cells that is responsible for recirculation, homing, multi-drug resistance, lymphocyte activation, and metastasis of many solid tumors. Its extracellular drug conjugate system includeo; a drug, a binding component that targets diseased cells. The company serves its clients across the US. Centrose is headquartered in Madison, Wisconsin, the US.

Centrose LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centrose LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centrose LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Centrose Raises USD0.2 Million in Venture Financing 10
Centrose Raises USD1 Million in Venture Financing 11
Centrose To Raise US$0.5 Million In Venture Financing 12
Centrose LLC – Key Competitors 13
Centrose LLC – Key Employees 14
Centrose LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Centrose LLC, Pharmaceuticals & Healthcare, Key Facts 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Centrose LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centrose Raises USD0.2 Million in Venture Financing 10
Centrose Raises USD1 Million in Venture Financing 11
Centrose To Raise US$0.5 Million In Venture Financing 12
Centrose LLC, Key Competitors 13
Centrose LLC, Key Employees 14

List of Figures
Centrose LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centrose LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • Amatsigroup SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Amatsigroup SAS (Amatsigroup) is a contract development manufacturing organization that offers human and veterinary pharmaceutical development through preclinical and clinical phases. The organization provides services such as bioservices, clinical trial supply, formulation development and m …
  • Enbridge Inc (ENB)-エネルギー分野:企業M&A・提携分析
    Summary Enbridge Inc. (Enbridge) is an integrated energy company. It carries out natural gas gathering, processing, transmission and distribution; transportation of crude oil; and marketing of petroleum products. The company also involved in power generation and transmission and has interests in ren …
  • Rosinter Restaurants Holding Ojsc:企業の戦略・SWOT・財務分析
    Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report Summary Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mercy Health:企業の戦略的SWOT分析
    Mercy Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complete Genomics Inc (Complete Genomics), a subsidiary of BGI Genomics Co Ltd, is a human genome sequencing solutions provider. The company offers sequencing technology, process automation technology and data management solutions. It has sequenced whole human genomes using sequencing instru …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natu …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Cree Inc (CREE)-エネルギー分野:企業M&A・提携分析
    Summary Cree, Inc. (Cree) is a lighting class LED's, LED lighting, and semiconductor solutions provider, that develops and manufactures semiconductor materials and devices principally based on silicon carbide (SiC), gallium nitride (GaN), and other related compounds. Cree’s product portfolio include …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Hexion Inc:企業の戦略的SWOT分析
    Hexion Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Didion Milling Inc.:企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mitralign Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mitralign Inc (Mitralign) is a medical device company that offers direct transcatheter annuloplasty system to treat both functional tricuspid regurgitation and mitral regurgitation. The company’s products include crossing wire, pledget delivery catheter and placation lock delivery catheter, …
  • General Mills Inc:戦略・SWOT・企業財務分析
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ablynx NV (ABLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ablynx NV (Ablynx) is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of nat …
  • Whole Foods Market Inc:戦略・SWOT・企業財務分析
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bioxyne Ltd (BXN):企業の財務・戦略的SWOT分析
    Bioxyne Ltd (BXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆